Attached files
| file | filename |
|---|---|
| EX-3.3 - EX 3.3 - AXIM BIOTECHNOLOGIES, INC. | certificateofamendment.pdf |
| EX-31.1 - EX 31.1 - AXIM BIOTECHNOLOGIES, INC. | ex331.htm |
| 10-Q - FORM 10-Q (6-30-14) - AXIM BIOTECHNOLOGIES, INC. | form10q.htm |
| EX-3.3 - EX 3.3 - AXIM BIOTECHNOLOGIES, INC. | certificateofamendment.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Report of AXIM International, Inc., a Nevada Corporation, (the “Company”) on Form 10-Q for the Quarter ended June 30, 2014, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned certify the following pursuant to Section 18, U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002:
|
1.
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
|
2.
|
The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
/s/ Dr. George Anastassov
Dr. George Anastassov
Chief Executive Officer
Chief Financial Officer
Principal Accounting Officer
August 14, 2014